|Mr. Christopher A. Bunka||Chairman & CEO||120k||N/A||1962|
|Mr. John M. Docherty||Pres & Director||117.21k||N/A||1969|
|Mr. Allan Spissinger||CFO, Principal Accounting Officer, Corp. Sec. & Treasurer||N/A||N/A||1969|
|Mr. Alex Blanchard||Mang. Corp. Communications & Investor Relations||N/A||N/A||N/A|
|Dr. Edward Ergenzinger||Advisor & Consultant||N/A||N/A||N/A|
Lexaria Bioscience Corp. focuses on the development of its proprietary nutrient infusion technologies for the production of superfoods, and the production of enhanced food products under the ViPova and Lexaria Energy brands. Its patented nutrient infusion technology, DehydraTECH provides increase in intestinal absorption rates; rapid delivery to the bloodstream; and important taste-masking benefits for orally administered bioactive molecules, including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs, nicotine, and other molecules. The company was formerly known as Lexaria Corp. and changed its name to Lexaria Bioscience Corp. April 2016. Lexaria Bioscience Corp. was founded in 2004 and is based in Kelowna, Canada.
Lexaria Bioscience Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.